Legal Representation
Attorney
Anne E. Naffziger
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 28, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 28, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 3, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 3, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 11, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 11, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 11, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 11, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 17, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 15, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 15, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 15, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 4, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 4, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 4, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 3, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 7, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 8, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biochemical reagents used for non-medical purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Reagents for use in scientific apparatus for chemical or biological analysis for scientific and research use
First Use Anywhere:
20240200
First Use in Commerce:
20240200
Class 005
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, immune rejection after transplantation, infectious diseases in the nature of tuberculosis and malaria; Medical diagnostic reagents for the analysis of body fluids for medical use
First Use Anywhere:
20240200
First Use in Commerce:
20240200
Additional Information
Pseudo Mark
DE CODI FI
Classification
International Classes
001
005